Molecular Imaging of Mediastinal Tumors
Article Sidebar
Main Article Content
ABSTRACT
Imaging plays a crucial role in the diagnosis, characterization, and management of mediastinal tumors. The mediastinal tumors discussed are categorized into anterior mediastinal tumors, including thymic tumors, teratoma/Germ cell tumors, lymphomas, and neurogenic tumors in the posterior mediastinum. Cross sectional imaging with computed tomography (CT) and magnetic resonance imaging (MRI) generates highly detailed images showing the precise location, size, extent of the tumor involvement, as well as its relationship with adjacent critical structures, especially vascular involvement and spinal canal extension, and differentiating solid and cystic masses. Molecular imaging with whole-body positron emission tomography (PET) when combined with CT or MRI can provide valuable information on tumor metabolism, staging, therapy planning, response assessment, and post-treatment monitoring for disease recurrence. With the advent of new non-FDG PET radiopharmaceuticals, the utility of molecular imaging in mediastinal tumors has further broadened. The purpose of this chapter is to provide a clear review of the role, advantages, pitfalls, and advancements of molecular imaging in each mediastinal tumor.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.
